This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Oct;4(10):528-9.

doi: 10.1038/ncpneuro0884. Epub 2008 Aug 26.

Neuroleptic discontinuation during dementia care: a recent trial and its implications for practice

Chiadi U Onyike¹

Affiliations

PMID: 18725920
DOI: 10.1038/ncpneuro0884

Comment

Neuroleptic discontinuation during dementia care: a recent trial and its implications for practice

Chiadi U Onyike. Nat Clin Pract Neurol. 2008 Oct.

. 2008 Oct;4(10):528-9.

doi: 10.1038/ncpneuro0884. Epub 2008 Aug 26.

Author

Chiadi U Onyike¹

Affiliation

¹ Frontotemporal Dementia and Young-Onset Dementias Clinic at The Johns Hopkins Hospital, Baltimore, MD 21205, USA. conyike1@johnshopkins.edu

PMID: 18725920
DOI: 10.1038/ncpneuro0884

No abstract available

PubMed Disclaimer

Comment on

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).
Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, Jacoby R, Kossakowski K, Yu LM, Juszczak E; Investigators DART AD. Ballard C, et al. PLoS Med. 2008 Apr 1;5(4):e76. doi: 10.1371/journal.pmed.0050076. PLoS Med. 2008. PMID: 18384230 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

Grants and funding

R01MH060626/MH/NIMH NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.